ASIA PACIFIC GENETIC TESTING MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC GENETIC TESTING MARKET FORECAST 2019-2027

ASIA PACIFIC GENETIC TESTING MARKET FORECAST 2019-2027

Genetic testing can reveal changes or alterations in the genes that may cause illness or disease. Genetic testing is experiencing a huge shift from general diagnostics to risk assessment situations. The global genetic testing market by the Asia Pacific was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.93% during the forecast period.

ASIA PACIFIC GENETIC TESTING MARKET FORECAST 2019-2027

Request free sample

Genetic testing can reveal changes or alterations in the genes that may cause illness or disease. Genetic testing is experiencing a huge shift from general diagnostics to risk assessment situations. The global genetic testing market by the Asia Pacific was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.93% during the forecast period.

The Asia Pacific is home to numerous developing economies such as China, India, and Japan, that acts as a better opportunity for genetic testing during the forecast period. The growing prevalence of chronic diseases such as Cancer, Alzheimer’s, etc. and the minimal risk associated with the genetic testing are the major growth drivers of the Asia Pacific genetic testing market. Moreover, the accuracy concerns related to genetic testing is the major factor which is hampering the growth in the Asia Pacific genetic testing market. The accuracy concerns related to genetic testing is one of the major factors which is hampering the growth in the Asia Pacific market. Moreover, the cost of the test also acts as the biggest challenge for the market, which is expected to hamper the growth of the global market.

China, India, Japan, South Korea, Australia and the Rest of APAC are considered for the market analysis in the report. China is the largest market in the Asia Pacific for genetic testing. The major factor which is driving the genetic testing market in China is the early detection of a genetic disorder. Increasing healthcare expenditure has improved healthcare infrastructure. The increasing life expectancy of individuals is also creating growth prospects in the China genetic testing market.

Laboratory Corporation of America Holdings, Abbott Laboratories, Pacific Biosciences of California, Inc., Natera, Inc., Danaher Corporation (Cepheid), Oxford Biodynamics Limited, Genentech, Inc., Integragen S.A, HTG Molecular Diagnostics, Inc., Illumina, Inc., 23ANDME, Qiagen N.V., DAAN Diagnostics Ltd., PerkinElmer, Inc., Roche Diagnostics Corporation, Genomictree, Inc., Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Luminex Corporation, and others have been the core market players which have been extensively studied in the report.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • MOLECULAR TESTING IS THE FASTEST GROWING GENETIC TESTING TECHNOLOGY
      • CANCER MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DISEASE
      • DIAGNOSTIC TESTING IS THE WIDELY USED GENETIC TESTING TYPE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVER
      • GROWING USAGE OF DIAGNOSING GENETIC DISORDERS
      • RISE IN INCIDENCE OF GENETIC DISEASES
      • MINIMAL HEALTH RISK ASSOCIATED WITH GENETIC TESTING
      • SURGE IN RNA PIPELINE TESTS
      • ADVANCES IN GENETIC TESTING FOR CANCER
      • GROWING AGEING POPULATION
    • MARKET RESTRAINTS
      • INACCURACIES IN RESULTS
      • REIMBURSEMENT ISSUES
      • PSYCHOLOGICAL IMPACT
      • LACK OF PRECISION IN TESTING
    • MARKET OPPORTUNITIES
      • GENETIC COUNSELLING
      • RISING CLINICAL APPLICATION FOR GENETIC TESTING
      • INNOVATION IN THE TREATMENT AND DIAGNOSTIC
    • MARKET CHALLENGES
      • HIGH COST OF MEDICATION AND TESTS
      • HIGH COST OF RAW MATERIAL
      • RISE IN GENETIC DISCRIMINATION
  1. MARKET BY TECHNOLOGY
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
    • MOLECULAR TESTING
  2. MARKET BY TYPE
    • CARRIER TESTING
    • DIAGNOSTIC TESTING
    • NEWBORN SCREENING
    • PREDICTIVE AND PRESYMPTOMATIC TESTING
    • PRENATAL TESTING
    • OTHER TYPES
  3. MARKET BY DISEASE
    • ALZHEIMER’S DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • SICKLE CELL ANEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • THALASSEMIA
    • HUNTINGTON’S DISEASE
    • RARE DISEASES
    • OTHER DISEASES
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF RIVALRY
    • KEY BUYING CRITERIA
      • COST
      • ACCURACY
      • AVAILABILITY
      • RELIABILITY
    • MARKET TRENDS
      • HEALTH INFORMATION IS RISING SIGNIFICANTLY
      • INCREASING DEMAND FOR PERSONALIZED MEDICINE
      • NEW PRODUCT LAUNCHES
      • TECHNOLOGY ADVANCEMENTS
    • PESTEL ANALYSIS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHIC ANALYSIS
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF APAC
  1. COMPANY PROFILING
    • 23ANDME
    • ABBOTT LABORATORIES
    • BIO-RAD LABORATORIES, INC.
    • DANAHER CORPORATION (CEPHEID)
    • DAAN DIAGNOSTICS LTD.
    • GENENTECH, INC.
    • HTG MOLECULAR DIAGNOSTICS, INC.
    • ILLUMINA, INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • LUMINEX CORPORATION
    • MYRIAD GENETICS, INC.
    • NATERA, INC.
    • OXFORD BIODYNAMICS LIMITED
    • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    • PERKINELMER, INC.
    • QIAGEN N.V.
    • ROCHE DIAGNOSTICS CORPORATION

 

TABLE LIST

TABLE 1        ASIA PACIFIC GENETIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 2        COST OF SELECTED DRUGS IN CANCER THERAPY

TABLE 3        ASIA PACIFIC GENETIC TESTING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 4        ASIA PACIFIC CYTOGENETIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 5        ASIA PACIFIC BIOCHEMICAL TESTING MARKET 2019-2027 ($ MILLION)

TABLE 6        ASIA PACIFIC MOLECULAR TESTING MARKET 2019-2027 ($ MILLION)

TABLE 7        ASIA PACIFIC GENETIC TESTING MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        ASIA PACIFIC CARRIER TESTING MARKET 2019-2027 ($ MILLION)

TABLE 9        ASIA PACIFIC DIAGNOSTIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 10      ASIA PACIFIC NEWBORN SCREENING MARKET 2019-2027 ($ MILLION)

TABLE 11      ASIA PACIFIC PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 12      ASIA PACIFIC PRENATAL TESTING MARKET 2019-2027 ($ MILLION)

TABLE 13      ASIA PACIFIC OTHER TYPES MARKET 2019-2027 ($ MILLION)

TABLE 14      ASIA PACIFIC GENETIC TESTING MARKET BY DISEASE 2019-2027 ($ MILLION)

TABLE 15      ASIA PACIFIC ALZHEIMER’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE 16      ASIA PACIFIC CANCER MARKET 2019-2027 ($ MILLION)

TABLE 17      ASIA PACIFIC CYSTIC FIBROSIS MARKET 2019-2027 ($ MILLION)

TABLE 18      ASIA PACIFIC SICKLE CELL ANEMIA MARKET 2019-2027 ($ MILLION)

TABLE 19      ASIA PACIFIC DUCHENNE MUSCULAR DYSTROPHY MARKET 2019-2027 ($ MILLION)

TABLE 20      ASIA PACIFIC THALASSEMIA MARKET 2019-2027 ($ MILLION)

TABLE 21      ASIA PACIFIC HUNTINGTON’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE 22      ASIA PACIFIC RARE DISEASES MARKET 2019-2027 ($ MILLION)

TABLE 23      ASIA PACIFIC OTHER DISEASES MARKET 2019-2027 ($ MILLION)

TABLE 24      ASIA PACIFIC ASIA PACIFIC GENETIC TESTING MARKET BY COUNTRIES 2019-2027 ($ MILLION)

FIGURE LIST 

FIGURE 1      ASIA PACIFIC GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 2      SAMPLES TYPES IN GENETIC TESTING

FIGURE 3      ASIA PACIFIC GERIATRIC POPULATION (65+) 2015 & 2020 (MILLION)

FIGURE 4      PROJECTIONS FOR THE PROPORTION OF GERIATRIC (60+) POPULATION IN 2015, 2030 & 2050

FIGURE 5      LAB AUTOMATION TECHNOLOGY BENEFITS GENETIC DIAGNOSTIC INDUSTRIES

FIGURE 6      ASIA PACIFIC GENETIC TESTING MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)

FIGURE 7      ASIA PACIFIC GENETIC TESTING MARKET BY CYTOGENETIC TESTING 2019-2027 ($ MILLION)

FIGURE 8      ASIA PACIFIC GENETIC TESTING MARKET BY BIOCHEMICAL TESTING 2019-2027 ($ MILLION)

FIGURE 9      ASIA PACIFIC GENETIC TESTING MARKET BY MOLECULAR TESTING 2019-2027 ($ MILLION)

FIGURE 10   ASIA PACIFIC GENETIC TESTING MARKET SHARE BY TYPE 2018 & 2027 (%)

FIGURE 11   ASIA PACIFIC GENETIC TESTING MARKET BY CARRIER TESTING 2019-2027 ($ MILLION)

FIGURE 12   ASIA PACIFIC GENETIC TESTING MARKET BY DIAGNOSTIC TESTING 2019-2027 ($ MILLION)

FIGURE 13   ASIA PACIFIC GENETIC TESTING MARKET BY NEWBORN SCREENING 2019-2027 ($ MILLION)

FIGURE 14   ASIA PACIFIC GENETIC TESTING MARKET BY PREDICTIVE AND PRESYMPTOMATIC TESTING 2019-2027 ($ MILLION)

FIGURE 15   ASIA PACIFIC GENETIC TESTING MARKET BY PRENATAL TESTING 2019-2027 ($ MILLION)

FIGURE 16   ASIA PACIFIC GENETIC TESTING MARKET BY OTHER TYPES 2019-2027 ($ MILLION)

FIGURE 17   ASIA PACIFIC GENETIC TESTING MARKET SHARE BY DISEASE 2018 & 2027 (%)

FIGURE 18   ASIA PACIFIC GENETIC TESTING MARKET BY ALZHEIMER’S DISEASE 2019-2027 ($ MILLION)

FIGURE 19   ASIA PACIFIC GENETIC TESTING MARKET BY CANCER 2019-2027 ($ MILLION)

FIGURE 20   ASIA PACIFIC GENETIC TESTING MARKET BY CYSTIC FIBROSIS 2019-2027 ($ MILLION)

FIGURE 21   ASIA PACIFIC GENETIC TESTING MARKET BY SICKLE CELL ANEMIA 2019-2027 ($ MILLION)

FIGURE 22   ASIA PACIFIC GENETIC TESTING MARKET BY DUCHENNE MUSCULAR DYSTROPHY 2019-2027 ($ MILLION)

FIGURE 23   ASIA PACIFIC GENETIC TESTING MARKET BY THALASSEMIA 2019-2027 ($ MILLION)

FIGURE 24   ASIA PACIFIC GENETIC TESTING MARKET BY HUNTINGTON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 25   ASIA PACIFIC GENETIC TESTING MARKET BY RARE DISEASES 2019-2027 ($ MILLION)

FIGURE 26   ASIA PACIFIC GENETIC TESTING MARKET BY OTHER DISEASES 2019-2027 ($ MILLION)

FIGURE 27   PORTER’S FIVE FORCE MODEL

FIGURE 28   PERCENTAGE OF AGING POPULATION IN ASIA 2010 AND 2050

FIGURE 29   INDIA GENETIC TESTING MARKET 2019-2027($ MILLION)

FIGURE 30   CHINA GENETIC TESTING MARKET 2019-2027 ($MILLION)

FIGURE 31   JAPAN GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 32   AUSTRALIA GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 33   SOUTH KOREA GENETIC TESTING MARKET 2019-2027($ MILLION)

FIGURE 34   REST OF APAC GENETIC TESTING MARKET 2019-2027($ MILLION)

  1. GEOGRAPHIC ANALYSIS
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF APAC
  1. MARKET BY TECHNOLOGY
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
    • MOLECULAR TESTING
  2. MARKET BY TYPE
    • CARRIER TESTING
    • DIAGNOSTIC TESTING
    • NEWBORN SCREENING
    • PREDICTIVE AND PRESYMPTOMATIC TESTING
    • PRENATAL TESTING
    • OTHER TYPES
  3. MARKET BY DISEASE
    • ALZHEIMER’S DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • SICKLE CELL ANEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • THALASSEMIA
    • HUNTINGTON’S DISEASE
    • RARE DISEASES
    • OTHER DISEASES

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now